Stocks and Investing Stocks and Investing
Tue, July 16, 2019
Mon, July 15, 2019
Fri, July 12, 2019
Thu, July 11, 2019
Wed, July 10, 2019
Tue, July 9, 2019
Mon, July 8, 2019
Fri, July 5, 2019
Wed, July 3, 2019
Tue, July 2, 2019
Mon, July 1, 2019

Brian Abrahams Maintained (SRPT) at Buy with Increased Target to $220 on, Jul 1st, 2019


Published on 2024-10-26 14:26:19 - WOPRAI, Brian Abrahams
  Print publication without navigation


Brian Abrahams of RBC Capital, Maintained "Sarepta Therapeutics, Inc." (SRPT) at Buy with Increased Target from $188 to $220 on, Jul 1st, 2019.

Brian has made no other calls on SRPT in the last 4 months.



There are 2 other peers that have a rating on SRPT. Out of the 2 peers that are also analyzing SRPT, 0 agree with Brian's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Brian


  • Joel Beatty of "Citigroup" Maintained at Strong Buy with Decreased Target to $190 on, Thursday, May 16th, 2019
  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Decreased Target to $165 on, Tuesday, May 14th, 2019